CSG’s New Trident Air Defence System and $635M Iowa Plant Fail to Soothe Investors

Czechoslovak Group's stock hits near 52-week low despite robust revenue, record backlog, and major US expansion. Investors await concrete growth evidence.

The Czechoslovak Group (CSG) is expanding on multiple fronts — a new air defence system in Paris, a top hire in Washington, and a half-billion-dollar factory in Iowa. Yet the company’s stock continues to bleed, closing at €12.80 on Wednesday, down more than 7% on the day and testing its 52-week low of €12.65. The shares have now lost nearly 65% of their value since the January 2026 IPO peak of €36.05.

Technical indicators underscore the severity of the sell-off. The relative strength index (RSI) has fallen to 28.2, deep into oversold territory. The stock trades well below both its 50-day moving average of €17.06 and its 100-day average of €22.70, suggesting the momentum remains firmly negative. No single trigger for the latest drop has been identified, pointing to what analysts describe as structural selling pressure.

Operationally, CSG continues to fire on all cylinders. At the Eurosatory defence exhibition in Paris on 15 June, the company unveiled the Trident air defence system, capable of engaging aircraft, helicopters, cruise missiles and drones. The Tadeas 4x4 armoured vehicle was also shown in a new command variant. Meanwhile, subsidiary AviaNera Technologies signed a cooperation agreement with Ukrainian Armor LLC to develop and supply engine solutions for Ukrainian rocket and drone systems, with plans for joint ventures and local technology transfer.

Across the Atlantic, CSG has dramatically stepped up its US presence. David Jacobs, a veteran of Northrop Grumman and Raytheon with over 15 years in the defence sector, has been appointed head of CSG Defense North America. His brief includes steering the long-term North America strategy and pursuing acquisitions. Jacobs previously led M&A strategy at Northrop and advised on more than 60 transactions worth over $200 billion during his time at Merrill Lynch. The move comes as CSG’s US subsidiary, MSM Group North America, prepares to break ground on a $635 million artillery shell factory in Iowa this summer.

The financials remain robust. First-quarter revenue rose by a double-digit percentage to €1.54 billion, while operating profit climbed to €372 million. The order backlog stands at a record €17 billion, and management has reiterated its full-year revenue guidance of approximately €7.5 billion. Additionally, CSG secured new contracts in the high double-digit millions from two European NATO members for mechanical and electronic fuses for large-calibre ammunition, to be produced by a newly formed joint venture with South Africa’s Reunert.

So why are investors running for the exits? The disconnect between operational strength and stock performance suggests the market is demanding concrete evidence that the pipeline of deals will translate into visible revenue and earnings growth. The Washington office and Jacobs’ appointment are designed to convert contacts into contracts, but until those orders materialise, the valuation remains under pressure. The next real test will come with the quarterly results — the first true check on the company’s post-IPO trajectory.